Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Schnorr

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Urology|June 15, 1999
Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSAK Jung, B Brux, M Lein, et al.
Voprosy Onkologii|February 24, 2004
[Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer]D I Danil'chenko, F Koenig, K Riedl, et al.
British Journal of Urology|September 2, 1998
The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy menM Lein, F Koenig, K Jung, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissueB Friedrich, K Jung, M Lein, et al.
Clinical Chemistry|July 1, 1996
Analytical performance and clinical validity of two free prostate-specific antigen assays comparedK Jung, C Stephan, M Lein, et al.
European Urology|November 6, 1998
p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancerH Schlechte, S V Lenk, T Löning, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1997
Elimination of serum free and total prostate-specific antigen after radical retropubic prostatectomyM Lein, B Brux, K Jung, et al.
Zeitschrift Fur Urologie Und Nephrologie|December 1, 1983
[High-voltage therapy of prostate cancer]D Schnorr, L U Kelly, H M Guddat, et al.
European Urology|October 12, 2000
Genetic analysis of Tp53 from urine sediment as a tool for diagnosing recurrence and residual of bladder carcinomaM D Sachs, H Schlechte, V S Lenk, et al.
International Journal of Cancer|January 6, 1997
Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in bloodW Henke, M Jung, K Jung, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Urology|June 15, 1999
Determination of alpha1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSAK Jung, B Brux, M Lein, et al.
Voprosy Onkologii|February 24, 2004
[Clinical significance of macroscopic 5-aminolevulinic acid (ALA)-inducer fluorescence in transurethral resection of non-invasive bladder cancer]D I Danil'chenko, F Koenig, K Riedl, et al.
British Journal of Urology|September 2, 1998
The percentage of free prostate specific antigen is an age-independent tumour marker for prostate cancer: establishment of reference ranges in a large population of healthy menM Lein, F Koenig, K Jung, et al.
European Journal of Cancer (Oxford, England : 1990)|April 22, 1999
Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissueB Friedrich, K Jung, M Lein, et al.
Clinical Chemistry|July 1, 1996
Analytical performance and clinical validity of two free prostate-specific antigen assays comparedK Jung, C Stephan, M Lein, et al.
European Urology|November 6, 1998
p53 tumour suppressor gene mutations in benign prostatic hyperplasia and prostate cancerH Schlechte, S V Lenk, T Löning, et al.
European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1997
Elimination of serum free and total prostate-specific antigen after radical retropubic prostatectomyM Lein, B Brux, K Jung, et al.
Zeitschrift Fur Urologie Und Nephrologie|December 1, 1983
[High-voltage therapy of prostate cancer]D Schnorr, L U Kelly, H M Guddat, et al.
European Urology|October 12, 2000
Genetic analysis of Tp53 from urine sediment as a tool for diagnosing recurrence and residual of bladder carcinomaM D Sachs, H Schlechte, V S Lenk, et al.
International Journal of Cancer|January 6, 1997
Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in bloodW Henke, M Jung, K Jung, et al.
Pageof 12